e picardial adipose tissue (EAT), located between the epicardium and underlying myocardium, constitutes 20% of the mass of the human heart. 1 EAT volume and coronary artery disease are strongly associated, even after accounting for overall body mass. [1] [2] [3] The association of EAT volume to heart disease has been attributed to paracrine signaling between EAT and adjacent coronary vessels and myocardium. 2 Despite its pathophysiological significance, the origin and paracrine signaling pathways that regulate EAT's formation and expansion are unclear.
The epicardium is a specialized form of mesothelium, the polarized epithelium that lines the surface of many organs, including the heart, lung, liver, and gut. In the developing heart, epicardial progenitors, marked by the expression of the transcription factor Wt1, undergo epithelial-to-mesenchymal transition (EMT) to form epicardium-derived cells (EPDCs), which migrate into the heart to form fibroblasts, smooth muscle cells, and, possibly, endothelial cells and cardiomyocytes. [4] [5] [6] In the adult heart, the epicardium is normally quiescent, but myocardial infarction (MI) reactivates a subset of its fetal program, inducing epicardial thickening, fetal gene reactivation, and differentiation of epicardial progenitors into fibroblasts and myofibroblasts. 7 The behavior and fate of injury-activated epicardium is guided by paracrine signals, as we showed in proof-of-concept experiments in which vascular endothelial growth factor A, delivered to myocardium at the time of myocardial infarction (MI) with modified RNA (modRNA), redirected epicardial progenitor fate by stimulating EPDC expansion, mobilizing their migration into subjacent myocardium, and directing their differentiation into endothelial cells. 8 Here we used a novel, in vivo, modRNA-based paracrine library screening approach to show that insulin-like growth factor 1 receptor (IGF1R) activation is sufficient to promote EAT formation in the context of MI. In this setting, IGF1R activation enhances the ability of Wt1-lineage cells to differentiate into adipocytes, and IGF1R inhibition or Wt1 inactivation blocked their MI-induced contribution to EAT. Our results establish IGF1R signaling as a key pathway that governs EAT formation and the fate decisions of Wt1-lineage cells in the context of myocardial injury.
MethODs
Please refer to Expanded Methods in the online-only Data Supplement for details.
Mice
All animal procedures were performed under protocols approved by the Boston Children's Hospital Institutional Care and Use Committee. Wt1 , and R26 mTmG alleles have been described previously. 6, [9] [10] [11] [12] Tamoxifen (Tam, 0.12 mg/g body weight) was administered to adult mice twice weekly for 3 weeks to induce CreERT2-mediated recombination. One week after completion of Tam dosing (to allow Tam clearance), the left anterior descending coronary artery was ligated to induce MI. 13 Paracrine factor modRNAs (100 µg/heart, Luciferase [Luc] modRNA serve as control) were injected into the infarct zone myocardium immediately after left anterior descending coronary artery ligation. 8 ModRNA gels were applied to the heart either at the time of left anterior descending coronary artery ligation or 2 weeks before by a lower thoracotomy, as described in the text. Procedures and measurements were performed blinded to genotype and treatment group. All animals that started an experimental protocol and survived to the measurement point were included.
synthesis of modrna
ModRNAs were in vitro transcribed from plasmid templates (sequences provided in the online-only Data Supplement Table I ) using a custom ribonucleoside blend of 3'-O-Me-m7G(5') ppp(5')G cap analog (6 mM, New England Biolabs), guanosine triphosphate (1.5 mM, USB), adenosine triphosphate (7.5 mM, USB), and 5-methylcytidine triphosphate and pseudouridine triphosphate (7.5 mM, TriLink Biotechnologies), as described previously 8, 14, 15 RNA was treated with Antarctic Phosphatase (New England Biolabs), quantitated by Nanodrop (Thermo Scientific), precipitated with ethanol and ammonium acetate, and resuspended in 10 mM TrisHCl, 1 mM EDTA. ModRNA was transfected into cultured cells with RNAiMAX (Life Technologies). The transfection mixture was added to cells cultured in DMEM with 2% FBS and 200 ng/mL B18R (eBioscience). ModRNA gel was made by mixing Cre modRNA (10 µL modRNA at 20 µg/µL), Lipofectamine 2000 (30 µL; Life Technologies), and 0.05% polyacrylic acid (10 µL; Sigma). The mixture was incubated for 15 minutes at room temperature to generate the gel, which was painted on the heart surface.
clinical Perspective
What is new?
• We show that a novel paracrine factor library screening approach enables in vivo dissection of signaling pathways that govern cardiac progenitor cell activity.
• We demonstrate that insulin-like growth factor 1 signaling is required in combination with the cellular environment created by myocardial infarction to stimulate differentiation of epicardial cells into adipocytes.
What are the clinical implications?
• Whereas stimulation of insulin-like growth factor 1 receptor may be advantageous for survival of cardiomyocytes and some cardiac progenitors, it may promote formation of epicardial adipose tissue in the injured heart. • These studies provide the foundation for future mechanistic studies on the pathophyosiolgical significance of epicardial adipose tissue.
• Our results suggest that insulin-like growth factor 1 receptor signaling that may be targeted to modulate epicardial adipose tissue formation.
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isolation and culture of Murine ePDcs and Mesenchymal stem cells
Mesenchymal stem cells were isolated from adult (6-8 weeks) CFW femurs as described previously. 16 Isolated cells were cultured in StemXvivo Osteogenic/Adipogenic Base media (R&D Systems) with Penicillin-Streptomycin (1:100). WT1 + EPDCs were isolated from heart explants of Wt1
GFPCre/+ mice 2 days after MI. Cardiac cells (nonmyocytes) were allowed to expand from heart explant cultures. After 2 weeks, green fluorescent protein (GFP + ) cells were isolated by fluorescence active cell sorting Aria III and plated in fibronectin-coated (5 ng/mL for 2 hours at 37ºC) wells of a 12-well plate (70 000 cells per well).
For enhancement of adipocyte differentiation in mesenchymal stem cells or EPDCs, culture medium (StemXvivo Osteogenic/Adipogenic Base media; R&D Systems) was supplemented with Adipogenic Supplement (1:20; R&D Systems). ModRNAs were transfected every 3 to 4 days during adipogenic differentiation. For detection of oil droplets, cultures were stained with saturated Oil red O solution (Sigma). 17 To quantitate Oil red O staining, plates were dried and extracted with 1 mL 100% isopropanol. After 10 minutes of incubation with gentle shaking, the OD 500 was recorded.
human ePDcs
Human EPDCs were obtained from atria of adult patients undergoing heart operations under a protocol approved by the Medical Ethics Committee of the Leiden University Medical Center. EPDCs were isolated as described and passaged ≤9 times. 18 immunostaining Immunostaining was performed on cryosections of hearts fixed by perfusion with 4% PFA with the antibodies listed in the online-only Data Supplement Table II . Quantification of immunostaining in cardiac sections was performed withg ImageJ Software.
rna isolation and gene expression Profiling
The peri-infarct zone near the apex was snap-frozen. Total RNA was isolated with the RNeasy mini kit (Qiagen) and reverse transcribed with Superscript III reverse transcriptase (Life Technologies). Real-time qPCR analyses were performed on a Mastercycler Realplex 4 Sequence Detector (Eppendoff) with SYBR Green (Quantitect SYBR Green PCR Kit; Qiagen). Fold changes in gene expression were determined by the ∂∂CT method and were presented relative to Gapdh internal control. PCR primer sequences are shown in the online-only Data Supplement Table III. For microarray gene expression profiling, WT1 GFPCre/+ mice underwent left anterior descending coronary artery ligation, and 7 days later the hearts were dissociated. GFP + EPDCs were isolated by fluorescence active cell sorting for GFP. RNA was isolated and used to probe Affymetrix Gene 1.0 ST arrays (n=3). Gene expression values were determined with Affy Power Tools, and the distribution of mean values were used to define the detectable gene expression threshold. Genes with gene ontology terms "receptor activity" or "plasma membrane" were manually curated to define a set of cell surface receptors. 
results
Recent lineage tracing studies indicate that EPDCs are 1 of the cell types that undergo adipogenic differentiation into epicardial fat, [19] [20] [21] and MI stimulates EPDC adipogenic differentiation. 20 To gain further insights into this process, we established a lineage-tracing system to measure MI-induced adipogenic differentiation of EPDCs. We used a pulse-labeled genetic lineage-tracing strategy, in which Wt1 regulatory elements drive epicardial expression of CreERT2 6 . In the presence of the inducing agent tamoxifen, CreERT2 indelibly activates the Rosa26
Tomato reporter, so these cells and their descendants express red fluorescent protein. 8, 19, 20 We refer to these cells durably labeled by Wt1
CreERT2 as Wt1-lineage cells (WT1LCs). Within the heart, WT1LCs are predominantly EPDCs, 6, 7 although Wt1 CreERT2 also labels other mesothelial cells within the chest, such as the cells of the pericardium and chest cavity. We pulse labeled adult mice by treating them with tamoxifen, performed left anterior descending coronary artery ligation to induce MI, and examined hearts 28 days later. Sham-operated mice did not develop obvious EAT (0/10), whereas 53% (10/19) of MI mice were positive for EAT ( Figure 1A, B) . Consistent with this observation, myocardial tissue expressed higher levels of adipocyte markers Fabp4, Adiponectin, Adipsin, and Pparg ( Figure 1C) . 22 The observed adipose tissue fulfilled 3 criteria for being EAT (online-only Data Supplement Figure I ) 21 : (1) it was perfused from the coronary arteries and not the systemic arteries; (2) it was histologically within the epicardium; and (3) it expressed Ucp1, a marker of brown fat, which was not expressed in peri-aortic fat. In Sham-operated mice, immunostaining of tissue sections showed that adipocytes, marked by Perilipin A, 19, 20 were infrequent and rarely overlapped with Wt1LCs. In contrast, after MI, adipocytes were more abundant and a subset were Wt1LCs, suggesting that MI stress induces EPDC differentiation into EAT ( Figure 1D ).
Quantitative analysis showed that 24.1% of Perilipin A + cardiac adipocytes were Wt1LCs ( Figure 1E ), consistent with reports that some cardiac adipocytes arise from epicardium. [19] [20] [21] The partial labeling of adipocytes may reflect incomplete labeling of the Wt1 lineage by tamoxi-fen but more likely reflects heterogeneous sources for EAT after MI. However, only a small fraction of Wt1LCs differentiated into adipocytes (Perilipin A + ; CD24 -; 12%) or preadipocytes (Perilipin A -; CD24 + ; 3%) ( Figure 1F ). 19 As a control experiment, we also traced the myocardial lineage with cardiomyocyte-specific Myh6-MerCreMer (Myh6-MCM). 10 Although EAT was induced by MI with equivalent frequency in Myh6-MCM; Rosa26
Tomato mice, we did not observe coexpression of the genetic lineage label in adipocytes ( Figure 1B , D, E). These data indicate that Wt1LCs, but not cardiomyocytes, differentiate into adipocytes in the context of MI.
Epicardial cells in the fetal heart and injured adult heart acquire plasticity by undergoing EMT to form EPDCs. 7 Epicardial EMT requires Wt1. 23, 24 Therefore, we hypothesized that EPDC differentiation into adipocytes in the injured adult heart requires epicardial Wt1 expression. Knockout of a conditional Wt1 flox allele 9 by induction of Wt1
CreERT2 in adults caused death from uncertain mechanisms within a few days, 25 precluding the use of this model to investigate the functional requirement of Wt1 in EAT formation. To circumvent this problem, we applied Cre modRNA gel 8 to the surface of Wt1 flox/flox ; Rosa26
Tomato hearts to locally inactivate Wt1 and simultaneously label EPDCs. In the heart, the Cre gel selectively labeled the epicardium and its derivatives, 8 although it could also label other cell populations that contact the Cre gel, including cells lining the pericardium, lungs, and chest cavity. We collectively refer to these as Cre gel lineage cells (CGLCs). In Wt1 flox/flox ; R26 Tomato mice treated with Cre gel, we continued to observe MI-induced formation of EAT ( Figure 1B) , consistent with the heterogeneous origin of epicardial fat. 19, 20 However, cells marked by Cre gel did not differentiate into adipocytes, indicating that Wt1 is required for the fate transition of CGLCs into adipocytes ( Figure 1D-F) . These results provide functional data that confirm the contribution of Wt1 + mesothelium to EAT. To further establish the adipogenic potential of EPDCs, we studied the capacity of in vitro-cultured primary EPDCs to differentiate into adipocytes. We induced MI in Wt1
GFPCre mice, which express GFP-Cre fusion protein from the endogenous Wt1 locus, 6 and then isolated post-MI EPDCs by fluorescence active cell sorting for GFP. When cultured in adipogenic media, the EPDCs differentiated into adipocytes, as demonstrated by Oil red O staining and upregulation of Fabp4, Adiponectin, Adipsin, and PPARγ (online-only Data Supplement Figure II) . These results indicate that EPDCs have the potential to differentiate into adipocytes, consistent with our in vivo data and recent reports. 19, 20 To investigate the role of paracrine signaling in MIinduced adipogenic differentiation of EPDCs, we first performed microarray expression profiling of post-MI EPDCs cells (marked by GFP in Wt1
GFPCre mice) to identify expressed receptors (Figure 2A ). From the microarray data, we selected a panel of 10 canonical candidate receptors expressed in these cells, along with 4 negative controls. To validate the expression of these receptors, we isolated an independent set of post-MI EPDCs. Quantitative reverse transcription polymerase chain reaction (PCR) showed that these cells robustly expressed epicardial markers Wt1 and Tbx18 26 and not cardiomyocyte markers Myh6, Tnni3, or Tnnt2 ( Figure 2B ), confirming that our isolation procedure captured EPDCs. The 10 candidate receptors identified by microarray were robustly expressed in EPDCs, whereas the 4 negative control receptors were not ( Figure 2B ). We further confirmed expression of these receptors by epicardial cells and their derivatives by immunostaining tissue sections of hearts after MI Wt1
GFPCre ( Figure 2C ). Epicardial cells, marked by GFP, coexpressed the 10 candidate receptors. EPDC expression of these receptors was further validated in cultured primary EPDCs (online-only Data Supplement Figure III) .
Having identified a number of EPDC-expressed receptors, we next asked whether overexpression of their cognate ligands at the time of MI would stimulate EAT formation. To efficiently test these factors for adipogenic activity within the bona fide in vivo context of heart injury, we took advantage of the power of modRNAs to induce myocardial expression of a pulse of paracrine factor. 8 We generated a paracrine factor modRNA library encoding the 10 candidate ligands plus vascular endothelial growth factor A, which we previously showed influences EPDC activity, 8 and luciferase (Luc) negative control. We then scored these factors for adipogenic activity when individually delivered to the heart at the time of MI operation. We found that 1 ligand, IGF1, robustly stimulated EAT formation after MI so that EAT was observed in 80% to 100% of hearts, compared with 25% to 50% at baseline or after treatment with other factors ( Figure 3A ). Unlike IGF1, the other 9 paracrine factors did not increase EAT formation after MI above baseline. It is interesting to note that IGF1 did not stimulate adipogenesis in normal hearts without the stress of MI (online-only Data Supplement Figure IV) . Increased IGF1-induced adipogenesis was confirmed by measuring expression levels of adipogenic lineage markers Fabp4, Adiponectin, Adipsin, and Pparg ( Figure 3B ).
Because our data ( Figure 1 ) and prior studies [19] [20] [21] indicated that EPDCs can differentiate into adipocytes after MI, we cultured primary EPDCs after MI and treated them with the 10 candidate ligand modRNAs. IGF1, but not the other 9 paracrine factors, stimulated adipogenesis ( Figure 3C ). Moreover, quantitative reverse transcription PCR comparing cultured EPDCs with or without IGF1 confirmed IGF1 stimulation of EPDC adipogenic differentiation ( Figure 3D ). To ask whether IGF1 similarly stimulated adipogenesis of human EPDCs, we obtained primary human EPDCs from patients undergoing operation for heart disease. These cells expressed the marker WT1, as expected for EPDCs. Consistent with the data from murine EPDCs, human EPDCs robustly expressed IGF1R ( Figure 3E ). Culture of these cells in IGF1 induced adipogenesis to the same extent as adipogenic media, as determined by Oil red O staining ( Figure 3F-G) . These data indicate that the IGF1-stimulated EPDC adipogenic pathway is conserved to humans.
We next used in vivo lineage-tracing strategies to directly measure the effect of each candidate paracrine factor on EPDC adipogenesis in vivo. Figure 4A shows representative confocal images of the lineage-tracing data obtained by Wt1
CreERT2 -mediated pulse labeling. With control Luc modRNA, we again observed that after MI, a small fraction of Perilipin A + adipocytes coexpressed the genetic marker of Wt1LCs ( Figure 4A , top panel). In contrast, IGF1 modRNA strongly increased the frequency of Perilipin A + cells in Wt1LCs ( Figure 4A , bottom panel). Quantitative analysis showed that IGF1 but not the other 9 paracrine factors increased the fraction of adipocytes that originate from Wt1LCs by ≈2-fold ( Figure 4B ). This finding was independently supported by Cre gel lineage tracing, which showed a similar increase of adipocytes in the Cre-labeled lineage, although the overall extent of contribution to adipocytes was lower likely because the gel labels a lower fraction of epicardial cells. EPDCs are a shared and predominant subset of both Wt1LCs and CGLCs. Thus, in combination with our in vitro data, these data suggest that IGF1 augmented the fraction of adipocyte-derived EPDCs. Although EAT originates from multiple sources, the increase in EPDC-derived adipocytes implies that IGF1 preferentially augments the contribution of EPDCs compared with other sources.
We also analyzed the fraction of EPDCs that express adipocyte or preadipocyte markers. IGF1, but not the other paracrine factors tested, strongly increased the 
A, Seven days after Wt1
GFPCre mice underwent myocardial infarction (MI) operation, EPDCs were isolated from dissociated hearts by fluorescence active cell sorting for green fluorescent protein (GFP FACS). EPDC RNA was profiled with microarrays. Plot shows the percentile expression rank of selected cell surface receptors and EPDC marker genes Wt1 and Tbx18. 10 canonical paracrine factor receptor further interrogated in this study are indicated in red. B, Expression levels of 10 canonical paracrine factor receptors (red) and additional marker genes (black, cardiomyocyte marker; green, EPDC marker; grey, receptors not expressed above microarray threshold) were measured by quantitative reverse transcription polymerase chain reaction (qRTPCR). RNA was isolated from FACS-purified EPDCs 3 days after MI operation. C, Immunostaining for 10 canonical paracrine factor receptors, 3 days after MI operation on Wt1
GFPCre mice. Bar = 50 μm. Mice underwent MI operation and concurrent injection of indicated paracrine factor-modified RNA (modRNA). A, Percentage of hearts with grossly visible epicardial fat after MI and injection of indicated paracrine modRNAs. Numbers inside bars indicate sample size (****P<0.0001; N.S., not significant; Fisher exact test). Inset shows H&E-stained sections from periinfarct and remote regions of IGF1 modRNA-injected heart. Red arrowheads indicate adipocytes within the expanded epicardial layer. Black arrowheads delineate the epicardial surface of the heart. B, IGF1 modRNA increased adipogenic marker gene expression 10 days after MI. Gene expression in left ventricular (LV) myocardium was measured by quantitative reverse transcription polymerase chain reaction (qRTPCR) and expressed as fold change in IGF1 modRNA compared with Luc treatment (n=3, ***P<0.001, t test). C, Adipogenic effect of indicated paracrine factors on primary cultured murine EPDCs. epicardium-derived cells (EPDCs) after MI were cultured in the presence of the indicated paracrine factors (100 µg/mL). The negative control was PBS, and the positive control was adipogenic media (R&D Systems Figure 5A ). Furthermore, IGF1-stimulated adipogenic differentiation of cultured EPDCs, measured by Oil red O staining, was inhibited 4-fold by the dominant-negative mutants ( Figure 5B and online-only Data Supplement Figure VIA ). This inhibitor effect was further confirmed by quantitative reverse transcription PCR measurement of adipogenic lineage marker expression in the EPDC cultures (online-only Data Supplement Figure VIB) .
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To study the requirement of IGF1 receptor signaling in EPDCs for their differentiation toward adipocytes in response to IGF1 modRNA and MI, we delivered the dominant-negative IGF1R antagonists to epicardial cells with modRNA gel. With Wt1
CreERT2
; Rosa26
Tomato lineage-tracing mice, we followed the fate of transduced Wt1LCs after MI and IGF1 modRNA treatment. IGF1R-DN or IRS1-DN modRNA gel treatment reduced the frequency of EAT after MI by ≈50% ( Figure 5C ), reduced the fraction of adipocytes that arise from Wt1LCs ( Figure 5D ), and decreased Wt1LC differentiation to preadipocytes and adipocytes ( Figure 5E ). We confirmed these results with modRNA gel to both Cre label cells derived from epicardium and to concurrently express IGF1R-DN or IRS1-DN. As in the Wt1
CreERT2 lineage-tracing model, inhibition of IGF1R signaling by either dominant-negative mutant in the Cre gel lineage-tracing model also reduced adipogenesis of Cre-marked cells in the context of IGF1 modRNA plus MI ( Figure 5F-H) . Indeed, the effect of the dominantnegative IGF1R inhibitors was slightly more pronounced in the Cre gel lineage-tracing model most likely because most cells that take up 1 modRNA when cotransfected with multiple modRNAs will concurrently take up all of the modRNAs (online-only Data Supplement Figure VII) . This effect would make lineage-traced and dominant-negative inhibitor expressing cells coincide more precisely in the modRNA cotransfection experiment ( Figure 5F -H) compared with separate Wt1
CreERT2 labeling and modRNA inhibitor gel expression ( Figure 5C-E) . Together both lineage-tracing studies indicate that in the heart after MI, exogenous IGF1 signals act on EPDCs by IGF1R to stimulate their adipogenic differentiation.
To determine whether the IGF1 signaling axis is required for MI-induced adipogenic differentiation of EPDCs in the absence of exogenously added IGF1 stimulation, we first asked whether MI activates the IGF1-IGF1R signaling axis in EPDCs. Immunostaining of peri-infarct myocardium 1 day after MI showed that IGF1 is upregulated in epicardial cells (Figure 6A-B) . This finding was further validated by quantitative reverse transcription PCR of IGF1 transcripts in peri-infarct tissue, which confirmed marked IGF1 upregulation ( Figure 6C ). Immunostaining for activated IGF1R (IGF1R phosphorylated on tyrosine 1161) likewise demonstrated its strong upregulation in EPDCs after MI ( Figure 6D ). We investigated hypoxia as a potential trigger for IGF1R activation in EPDCs by culturing EPDCs in normoxic or hypoxic conditions in the presence or absence of exogenous IGF1 (online-only Data Supplement Figure VIII) . In the absence of exogenous IGF1, hypoxia had little effect on total or activated IGF1R. However, the addition of exogenous IGF1 in combination with hypoxia increased IGF1R activation, even in the face of decreased total IGF1R. These data indicate that hypoxia strengthens IGF1R activation in EPDCs, suggesting a potential mechanism for the observed interaction between IGF1 and MI in inducing adipogenesis.
Next, we induced MI without the addition of IGF1 modRNA and used modRNA gel to both Cre label EPDCs and express IGF1R-DN or IRS1-DN, thereby selectively inhibiting IGF1R signaling in CGLCs, including EPDCs. IG-F1R inhibition reduced the fraction of hearts with grossly evident EAT ( Figure 6E ) and reduced the expression of adipogenic markers ( Figure 6F) . Evaluation of the fate of CGLCs by confocal imaging showed that infrequent Perilipin A + adipocytes expressed the lineage tracer in hearts after MI with intact IGF1R signaling (Luc modRNA gel treatment; arrows, Figure 6G , top panel). Inhibition of IGF1R signaling in CGLCs with either IGF1R-DN or IRS1-DN abolished their differentiation into EAT ( Figure 6G , bottom 2 panels). This finding was confirmed by quantitative analysis of imaging data, which showed that the fraction of adipocytes derived from CGLCs ( Figure 6H) Figure 3 continued. culture with or without IGF1, gene expression was measured by qRTPCR and displayed as a ratio of expression in IGF1 stimulated to unstimulated cells. Dotted line indicates no change in expression (ratio=1; n=3, ** P<0.01, *** P<0.001, t test). E, Expression of Wt1 and IGFR1 relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in human primary EPDCs. Gene expression was measured by qRTPCR. F and G, IGF1 stimulated adipogenesis in human EPDCs. Negative control, standard media; positive control, adiopogenic media. Fixed cells were stained with Oil red O. Oil red O signal was quantitated as described for panel (C). and the fraction of labeled CGLCs that expressed adipocyte markers ( Figure 6I) were strongly decreased by IGF1R inhibition. Because EPDCs are the predominant constituent of CGLCs, together these data suggest that IGF1R signaling is activated in EPDCs after MI and is required for MI-induced EPDC differentiation into adipocytes.
DiscussiOn
Our work illustrates the power of modRNA paracrine factor libraries to discover novel in vivo functions of these factors as regulators of progenitor cell fate. By enabling the delivery of pulses of a panel of paracrine factor at the relevant time and place in an in vivo disease context, this approach allows rapid identification of signaling pathways that regulate tissue injury responses in vivo. Here, we used a modRNA paracrine factor screen to identify IGF1 as a factor required for EAT formation.
EAT has an intimate anatomic relationship to the coronary vasculature and myocardium. Epidemiological studies demonstrate that EAT is closely related to coronary artery disease, suggesting that paracrine or metabolic signaling between EAT and the coronary vessels and myocardium influence the evolution of atherosclerotic lesions and heart disease.
1-3 Our work shows that IGF1 receptor signaling drives EAT formation by directing progenitor cells into the adipocyte lineage in the context of MI. This function is consistent with the proadipogenic ac- tivity of IGF1 on preadipocytes and mesenchymal stem cells. 29 The IGF1 pathway has been linked to cardioprotection 30 and enhanced cardiomyocyte differentiation of cardiac progenitor cells. 31 Our results delineate potential negative consequences of IGF1 pathway activation and will need to be considered when evaluating therapeutic interventions based on manipulating the IGF1 pathway. However, because EAT shares common developmental origins with other types of visceral fat, 19 IGF1 may also control expansion of other visceral fat depots. Targeting such signaling pathways or stabilizing mesothelial cells in their epithelial state may be novel approaches to treating the burgeoning problems of ischemic heart disease and obesity.
Consistent with prior studies, [19] [20] [21] our work indicated that epicardial progenitors are a source of EAT. This result was supported by 2 independent lineage-tracing strategies, both of which pointed to EPDCs as the IGF1-responsive adipogenic progenitor ( Figure 7 ): IGF1 receptor activation increased their MI-induced differentiation into adipocytes, whereas IGF1 receptor inhibition prevented this lineage conversion. The adipogenic effect of IGF1 was conserved in humans EPDCs. Thus, IGF1 A through D, Wt1 CreERT2/+ Rosa26 Tomato mice were induced with tamoxifen and then underwent sham or MI operation. The next day, hearts were fixed, sectioned, and stained for the Wt1LC genetic marker and IGF1 protein (A). The fraction of Wt1LCs coexpressing IGF1 were quantitated (B). Peri-infarct LV or remote RV tissue underwent quantitative reverse transcription polymerase chain reaction (qRTPCR) to measure the IGF1 transcript levels 1 day after MI (C). Peri-infarct myocardium was stained (Continued ) signaling is a physiological switch that promotes adipogenic differentiation of epicardial progenitor cells.
It is important to note that the IGF1-driven progenitor fate switch appeared to be operative only within a brief time window after MI because IGF1 activation did not stimulate adipogenic differentiation of progenitor cells in the absence of MI, and transient inhibition of IGF1 receptor signaling with modRNA-mediated expression of dominant negative proteins was sufficient to suppress MI-induced differentiation into adipocytes. The requirement for MI in combination with IGF1 to stimulate progenitor differentiation into adipocytes may result from 2 factors. First, our data suggest that IGF1 more strongly activates IGF1R under hypoxic conditions. Second, MI activation of progenitors may be a prerequisite for their differentiation into adipocytes. MI activates epicardial EMT, which transforms epicardial cells from epithelial cells into mesenchymal cells with greater developmental plasticity. 7 Supporting this conclusion, Wt1 is required for epicardial EMT, 23, 24 and MI-induced adipogenesis likewise required Wt1 (Figure 7) .
Infiltration of myocardium by adipocytes is also a hallmark of arrhythmogenic cardiomyopathy, most often caused by mutations in desmosome proteins. 38 Presently, the origin of this adipose tissue is controversial, and our studies suggest the possibility that desmosomal mutations alter the behavior of epicardial progenitors and direct them to migrate into the myocardium and form adipocytes. The epicardium to endocardium direction of adipogenic involvement in this disease would be consistent with this possibility. Lombardi et al 39 showed that adipogenic cells in a mouse model of this disease are marked by Isl1Cre. Although this finding was interpreted as demonstrating a second heart field origin of the adiogenic cells, Isl1Cre also marks epicardial cells, 40 and thus the results are consistent with epicardial contribution to adipogenesis in arrhythmogenic cardiomyopathy.
Delineating lineage relationships between populations with Cre labeling approaches is vulnerable to misinterpretation. In this study, we showed that the IGF1R-responsive adipogenic progenitor population is labeled by both Wt1
CreERT2 and Cre modRNA. Within the heart, EPDCs are the population that would be labeled by both techniques. However, the MI model distorts normal tissue planes, removes portions of the pericardium, and can cause cardiac adhesions to surrounding tissues. In this setting, noncardiac Wt1 + cells from surrounding tissues, such as the mesothelial lining of the chest wall, could contact and infiltrate the heart. Such cells may also be labeled by Cre modRNA gel. The adipocytes in our study had characteristics of EAT, including expression of the brown fat marker UCP1, perfusion by coronary vessels, and covering by epicardium, which excludes mistaking simple pericardial adhesions for EAT. However, we cannot fully exclude the possibility that Wt1 + cells lining the surface of other parts of the chest cavity could have infiltrated EAT and differentiated into EAT-like adipocytes. Myocardial infarction (MI) induces epicardial epithelial to mesenchymal transition (EMT) to form epicardium-derived cells (EPDCs), a process that requires WT1. EPDCs have lineage plasticity and endogenously tend to differentiate into fibroblasts, smooth muscle cells, and myofibroblasts. Vascular endothelial growth factor A (VEGFA) 8 and Thymosin B4 (TB4) 32 guide EPDCs to differentiate into endothelial cells, 33 and here we show that insulin-like growth factor 1 (IGF1) guides EPDCs to differentiate into adipocytes. Cardiomyocytes may be an alternative fate of EPDCs, 6, 26, 34, 35 although this notion remains controversial.
36,37 Figure 6 continued. for the Wt1LC genetic marker and IGF1R or activated IGF1R (IGF1R-pY1161; D). MI upregulated IGF1 expression and activated IGF1R in EPDCs. E through I, Rosa26 Tomato/+ mice underwent MI operation and were treated with modRNA containing Cre and either IGF1R-DN, IRS-1-DN, or Luc (negative control). The percentage of hearts with grossly evident EAT was determined 28 days later (E). Numbers above bar indicate fat positive and all hearts. Inhibition of IGF1R signaling significantly decreased the frequency of epicardial adipose tissue (EAT) (P=0.04, Fisher exact test using pooled DN modRNA groups compared with Luc control). LV myocardial expression of adipocyte marker genes in hearts treated with DN modRNAs compared with Luc modRNA was measured by qRTPCR (F; dotted line indicates level in Luc control) (n=3, ***P<0.001, t test). Heart sections were imaged with a confocal microscope. Representative images are shown in (G). Arrowheads indicate adipocytes coexpressing the Cre gel-activated lineage tracer. Bar = 10 µm. The fraction of perilipin A + adipocytes that coexpressed the Cre gel lineage cells (CGLC) genetic marker (H) and the fraction of CGLCs that differentiated into mature adipocytes, adipogenic progenitors, or nonadipocytes (I) was quantified (***P<0.001, t test).
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